Binyi Xiao

751 total citations
37 papers, 391 citations indexed

About

Binyi Xiao is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Binyi Xiao has authored 37 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 12 papers in Surgery. Recurrent topics in Binyi Xiao's work include Genetic factors in colorectal cancer (18 papers), Colorectal Cancer Surgical Treatments (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Binyi Xiao is often cited by papers focused on Genetic factors in colorectal cancer (18 papers), Colorectal Cancer Surgical Treatments (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Binyi Xiao collaborates with scholars based in China, United States and Ethiopia. Binyi Xiao's co-authors include Zhizhong Pan, Peirong Ding, Jinghua Tang, Jianhong Peng, Jiang Wu, Ling-Heng Kong, Qiaoqi Sui, Qingjian Ou, Kai Han and Xiaojun Wu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Binyi Xiao

36 papers receiving 387 citations

Peers

Countries citing papers authored by Binyi Xiao

Since Specialization

Citations

This map shows the geographic impact of Binyi Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binyi Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binyi Xiao more than expected).

Fields of papers citing papers by Binyi Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binyi Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binyi Xiao. The network helps show where Binyi Xiao may publish in the future.

Co-authorship network of co-authors of Binyi Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Binyi Xiao. A scholar is included among the top collaborators of Binyi Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binyi Xiao. Binyi Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study 2025 ·npj Precision Oncology ·Zhenlin Hou, (unknown), Weiwei Xiao, Qiaoqi Sui, Kai Han, Binyi Xiao, Yuan Li, Wei-Jian Mei, Jiehai Yu, (unknown), Qichen Chen, (unknown), Dandan Li, Xiaoshi Zhang, Qiaoxuan Wang, Zhizhong Pan, (unknown), Peirong Ding	1
2	Hereditary leptomeningeal transthyretin amyloidosis with heterozygous TTR mutation: a case report and literature review 2025 ·Orphanet Journal of Rare Diseases ·Hongtao Chen, Ye Tian, Jue Zhang, Binyi Xiao, Yang Ke, Yali Zhang	0
3	Development and validation of a logistic regression model for the diagnosis of colorectal cancer 2025 ·Scientific Reports ·(unknown), W. Zhang, Qichen Chen, Fei Xiao, Xia Yang, Binyi Xiao, (unknown), (unknown), Xueying Li, Desen Wan, Zhizhong Pan, Jianhong Peng, Xiaojun Wu	5
4	The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study 2024 ·BMC Cancer ·(unknown), Jinghua Tang, (unknown), Jiang Wu, Yuan Li, Ling-Heng Kong, Kai Han, Zhenlin Hou, Chenzhi Zhang, (unknown), Linjie Zhang, Qiaoqi Sui, Binyi Xiao, Wei-Jian Mei, Jiehai Yu, (unknown), Zhizhong Pan, Peirong Ding	2
5	Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis 2024 ·Annals of Medicine ·Weihao Li, Lan Jin, (unknown), Rong Yang, Jiayu Wang, Jiahua He, Binyi Xiao, Qingjian Ou, Yujing Fang, (unknown), (unknown), Zhizhong Z. Pan, (unknown), Xiaojun Wu	1
6	MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases 2024 ·Clinical & Translational Oncology ·(unknown), Weihao Li, Jiayu Wang, Xiaojun Wu, (unknown), Junzhong Lin, Binyi Xiao, (unknown), (unknown), Song Wang, (unknown), Yuguang Lin, (unknown), (unknown), Zhizhong Pan, Jianhong Peng	1
7	Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer 2023 ·Journal of the National Comprehensive Cancer Network ·Binyi Xiao, Xuan Zhang, (unknown), Dandan Li, Jiang Wu, Ling-Heng Kong, Jinghua Tang, Kai Han, (unknown), Wei-Jian Mei, Jian Xiao, Zhizhong Pan, Yunfeng Li, Xiaoshi Zhang, Peirong Ding	26
8	A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions 2023 ·Cancer Medicine ·Yuan Li, Bin Li, Rou Jiang, (unknown), (unknown), Jie Yuan, (unknown), (unknown), Yuyu Zhang, Wei-Jian Mei, (unknown), Binyi Xiao, Ling-Heng Kong, Kai Han, Jinghua Tang, Jiang Wu, Zhizhong Pan, Shenyan Zhang, Peirong Ding	9
9	Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients 2023 ·European Journal of Cancer ·Jiehai Yu, Binyi Xiao, Jinghua Tang, Dandan Li, Fang Wang, Ya Ding, Kai Han, Ling-Heng Kong, Yihong Ling, Wei-Jian Mei, (unknown), (unknown), Wan-jun Yang, Zhizhong Pan, Xiaoshi Zhang, Jiang Wu, Peirong Ding	11
10	Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study 2022 ·European Journal of Cancer ·Qiaoxuan Wang, Binyi Xiao, Yong Cheng, Aiwen Wu, Tao Zhang, Hui Wang, Xuan Zhang, Weixin Huang, Jinghua Tang, Jiang Wu, Scott R. Steele, Smitha Krishnamurthi, Yuan Li, Jian Cai, Ling-Heng Kong, Dandan Li, Zhizhong Pan, Xiaoshi Zhang, Peirong Ding	19
11	DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer 2022 ·Clinical & Translational Oncology ·Yuan Li, (unknown), Ling-Heng Kong, Jiang Wu, Jinghua Tang, Kai Han, Zhenlin Hou, Chenzhi Zhang, (unknown), Linjie Zhang, Qiaoqi Sui, Binyi Xiao, Wei-Jian Mei, Yanbo Xu, Jiehai Yu, (unknown), Zhizhong Pan, Peirong Ding	1
12	Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Qiaoqi Sui, Dingxin Liu, Jiang Wu, Jinghua Tang, Ling-Heng Kong, Kai Han, (unknown), Yuan Li, Qingjian Ou, Binyi Xiao, Guochen Liu, Yihong Ling, Jiewei Chen, Zexian Liu, Zhixiang Zuo, Zhizhong Pan, Penghui Zhou, Jian Zheng, Peirong Ding	43
13	RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases 2021 ·Pathology & Oncology Research ·Yuxiang Deng, Long Yu, Yujie Zhao, Jianhong Peng, Yanbo Xu, (unknown), Binyi Xiao, Songran Liu, Mei Li, Yujing Fang, Zhizhong Pan	8
14	Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer 2021 ·Cancer Cell International ·Jianhong Peng, Weihao Li, Wenhua Fan, Rongxin Zhang, Xinyue Li, Binyi Xiao, (unknown), Desen Wan, Zhizhong Pan, Junzhong Lin, Xiaojun Wu	6
15	Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis 2020 ·Annals of Translational Medicine ·Binyi Xiao, Jianhong Peng, Yongchun Wang, Yuxiang Deng, Qingjian Ou, (unknown), Junzhong Lin, Zhizhong Pan, Lin Zhang	14
16	Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study 2019 ·BMC Cancer ·Qiaoqi Sui, Jian Zheng, Dingxin Liu, Jianhong Peng, Qingjian Ou, Jinghua Tang, Yuan Li, Ling-Heng Kong, Jiang Wu, Binyi Xiao, Xue Chao, Zhizhong Pan, Huizhong Zhang, Pei-Rong Ding	16
17	Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection 2019 ·Journal of Cancer ·Yuxiang Deng, Yujie Zhao, Wenhua Fan, Jianhong Peng, (unknown), (unknown), Binyi Xiao, (unknown), Zhizhong Pan	2
18	Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer 2017 ·Cancer Management and Research ·Binyi Xiao, Jianhong Peng, Rongxin Zhang, Jing Xu, Yongchun Wang, Yujing Fang, Junzhong Lin, Zhizhong Pan, (unknown)	13
19	RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma 2017 ·Theranostics ·Tianze Liu, Wenbin Li, Wenjing Lü, Miao Chen, Meihua Luo, Changlin Zhang, Yixin Li, Ge Qin, Dingbo Shi, Binyi Xiao, Huijuan Qiu, Wendan Yu, Lan Kang, Tiebang Kang, Wenlin Huang, (unknown), Xiaojun Wu, Wuguo Deng	25
20	Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas 2017 ·Molecular Cancer ·Jingshu Wang, Kun Zou, Feng Xu, Miao Chen, Cong Li, Ranran Tang, Xuan Yang, Meihua Luo, Wangbing Chen, Huijuan Qiu, Ge Qin, Yixin Li, Changlin Zhang, Binyi Xiao, Lan Kang, Tiebang Kang, Wenlin Huang, (unknown), Xiaojun Wu, Wuguo Deng	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact